IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
LEARN MORE
IJPC on Facebook
 
Sign On
  • Home
  • About
    • The Journal
    • Editor-In-Chief
    • Editorial Calendar
    • Submissions
    • Advertising
    • Permissions & Reprints
    • Privacy Policy
  • Subscriptions
    • Subscribe
    • Renew
    • Prices
    • Free Sample
  • Store
    • View Shopping Cart
    • Back Issues
    • Articles
    • Library Archives
    • Compounding Theme Archives
    • Other Products
  • Resources
    • Supplemental Content and Errata
    • Training and Education
    • IJPC-PCAB SOP Matrix
    • USP GAP Analysis
    • Compounders' Network List
    • Patient Information
    • Videos
    • Compounders' Resource Directory
  • Account
  • Contact US

Library CD
Volume 2, 1998 CD
Six back issues from 1998 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.
Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 2 No. 1 January/February 1998 Hormone Replacement
Vol. 2 No. 2 March/April 1998 Pain Management
Vol. 2 No. 3 May/June 1998 Compounding Ophthalmics
Vol. 2 No. 4 July/August 1998 Dermatology
Vol. 2 No. 5 September/October 1998 Parenteral Nutrition Solutions
Vol. 2 No. 6 November/December 1998 Environmental Compounds

Volume 2, 1998 CD ARTICLES

Volume 2, 1998 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Essential Truths About HRT Vol. 2 No. 1 10
Interview on HRT: Christiane Northrup, MD, FACOG Vol. 2 No. 1 12
HRT and the Continuing Education of Health Care Professionals Vol. 2 No. 1 18
Estrogen and Breast Cancer: Is There a Link? Vol. 2 No. 1 21
Estrogen in the Treatment and Prevention of Alzheimer's Disease Vol. 2 No. 1 24
Reviews: Books on HRT Vol. 2 No. 1 30
The Formulation and Use of Placebo Dosage Forms in Pharmacy Vol. 2 No. 1 35
Hiring Good People Vol. 2 No. 1 38
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 2. Confidence Intervals and p Values Vol. 2 No. 1 42
Estradiol 1-mg Vaginal Suppositories Vol. 2 No. 1 48
Estradiol Topical Gel Vol. 2 No. 1 49
Estradiol Vaginal Cream (0.2%) Vol. 2 No. 1 50
Estradiol Vaginal Gel (0.2%) Vol. 2 No. 1 51
Methyltestosterone 6-mg/g Gel Vol. 2 No. 1 52
Progesterone Enema 100- and 200-mg/mL Vol. 2 No. 1 53
Progesterone-Estradiol-Testosterone in Oil Capsules Vol. 2 No. 1 54
Progesterone in Oil Capsules Vol. 2 No. 1 55
Progesterone Nasal Spray (2%) Vol. 2 No. 1 56
Progesterone Oral Suspension (40-mg/mL) Vol. 2 No. 1 57
Progesterone 3% Vaginal Gel Vol. 2 No. 1 58
Progesterone Troches (100-mg, Soft) Vol. 2 No. 1 59
Progesterone Troches (300-mg, Hard) Vol. 2 No. 1 60
Progesterone Troches (400-mg, Soft) Vol. 2 No. 1 61
Progesterone 200-mg Buccal Tablets Vol. 2 No. 1 62
Progesterone 200-mg Linguets (Soft) Vol. 2 No. 1 63
Progesterone Vaginal Cream (5%) Vol. 2 No. 1 64
Progesterone Vaginal Suppositories (Fatty Acid Base) Vol. 2 No. 1 65
Progesterone Vaginal Suppositories (Polyethylene Glycol Bases) Vol. 2 No. 1 66
Testosterone Propionate Gel Vol. 2 No. 1 67
Testosterone Propionate 100-mg/6 mL Cream Vol. 2 No. 1 68
Testosterone Propionate 2% Ointment Vol. 2 No. 1 69
Testosterone 0.625-mg Troches Vol. 2 No. 1 70
Extemporaneous Lozenge Formulations Vol. 2 No. 1 71
Silicates: Bentonite, Magnesium Aluminum Silicate, Silica Gel and Colloidal Silicon Dioxide - , Featured Excipient: Vol. 2 No. 1 73
Calculations Vol. 2 No. 1 74
Glasnapp's Rule Vol. 2 No. 1 75
The pH Value of Urea Solutions in Purified Water Vol. 2 No. 1 76
Standard Operating Procedure for Particulate Testing for Sterile Products Vol. 2 No. 1 78
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion Vol. 2 No. 1 79
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Vol. 2 No. 1 83
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Vol. 2 No. 1 89
PostScription: Independent Pharmacy: Alive and Well Vol. 2 No. 1 96
Compounding for Pain Management Vol. 2 No. 2 104
Opioids for Noncancer Pain: From Controversy to Consensus Vol. 2 No. 2 106
Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base Vol. 2 No. 2 110
Managing Pain in the Terminally Ill Vol. 2 No. 2 111
The Symptom Relief Kit for Hospice Patients Vol. 2 No. 2 116
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients Vol. 2 No. 2 118
Profile of a Practice/Patient Handout: DHE Nasal Spray Vol. 2 No. 2 120
Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain Vol. 2 No. 2 122
Firing an Employee - Without Getting Burned Vol. 2 No. 2 130
Problems with Third-Party Payments for Compounded Prescriptions Vol. 2 No. 2 134
The pH Value of Common Household Products Using Meters, Papers and Sticks Vol. 2 No. 2 137
Accuracy in Prescriptions Compounded by Pharmacy Students Vol. 2 No. 2 139
Analgesic Medication Stick Vol. 2 No. 2 144
Buprenorphine HCl 150-mcg/100 mcL Nasal Spray Vol. 2 No. 2 145
Capsaicin 0.05% Topical Gel Vol. 2 No. 2 146
Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis Vol. 2 No. 2 147
Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules Vol. 2 No. 2 148
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray Vol. 2 No. 2 149
Dihydroergotamine Mesylate 1-mg Troches Vol. 2 No. 2 150
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories Vol. 2 No. 2 151
Fentanyl 50-mcg Chewable Gummy Gels Vol. 2 No. 2 152
Fentanyl 300-mcg/6-mL Inhalation Vol. 2 No. 2 153
Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel Vol. 2 No. 2 154
Lidocaine 30% Lip Balm Vol. 2 No. 2 155
Meperidine HCl 50-mg/mL Nasal Solution Vol. 2 No. 2 156
Morphine Sulfate 25-mg Troche Vol. 2 No. 2 157
Sumatriptan 5-mg/mL Oral Liquid Vol. 2 No. 2 158
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Vol. 2 No. 2 159
Vehicles for Compounding Oral Liquids: Some Practical Considerations Vol. 2 No. 2 160
Silicates: Attapulgite, Kaolin, Kieselguhr, Magnesium Trisilicate, Pumice, Talc - Featured Excipient: Vol. 2 No. 2 162
Calculations Vol. 2 No. 2 164
Class A Prescription Torsion Balance Performance Tests Vol. 2 No. 2 166
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 2 No. 2 168
Stability of Indomethacin in 0.9% Sodium Chloride Injection Vol. 2 No. 2 170
PostScription: Hey, Let's Work Together! Vol. 2 No. 2 176
Compounding Ophthalmic Preparations Vol. 2 No. 3 184
Isotonic Sodium Chloride Solution Vehicle for Ophthalmics Vol. 2 No. 3 188
Boric Acid Solution Vehicle for Ophthalmic Preparations Vol. 2 No. 3 188
Boric Acid Solution Vehicle without Benzalkonium Chloride for Ophthmalic Preparations Vol. 2 No. 3 188
Phosphate Buffer System Vehicle for Ophthalmics Vol. 2 No. 3 188
Ophthalmic Compounding: Techniques for Achieving Sterility Vol. 2 No. 3 189
Buffer Solutions for Ophthalmic Preparations Vol. 2 No. 3 190
Palitzsch Buffer Acid Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Sodium Acetate-Boric Acid-Alkaline Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Sorensen's Modified Phosphate Buffer-Acid Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Sorensen's Modified Phosphate Buffer- Alkaline Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Acid Stock Solution Vol. 2 No. 3 190
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Alkaline Stock Solution Vol. 2 No. 3 190
Feldman Buffer for Ophthalmic Preparations-Acid Stock Solution Vol. 2 No. 3 190
Feldman Buffer for Ophthalmic Preparations-Alkaline Stock Solution Vol. 2 No. 3 190
Palitzsch Buffer Alkaline Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Sodium Acetate-Boric Acid-Acid Stock Solution for Ophthalmic Preparations Vol. 2 No. 3 190
Gilford Ophthalmic Buffer-Acid Stock Solution Vol. 2 No. 3 191
Gilford Ophthalmic Buffer-Alkaline Stock Solution Vol. 2 No. 3 191
Anatomy of the Eye Vol. 2 No. 3 191
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Vol. 2 No. 3 192
Ophthalmic Solutions in Cataract Surgery Vol. 2 No. 3 196
A Glimpse Into the Future Vol. 2 No. 3 203
An Eye to Success Vol. 2 No. 3 205
Veterinary Dexamethasone 0.1% Ophthalmic Ointment Vol. 2 No. 3 206
Veterinary 2-deoxy-D-glucose Ophthalmic Ointment Vol. 2 No. 3 206
Ophthalmic Compounding for Animals - Equine Ophthalmic Ointments and Treatment of Epithelial Calcification of the Cornea with EDTA 1% Vol. 2 No. 3 206
Eyecups: The Beginning of Eye Irrigation and Treatment Vol. 2 No. 3 208
Nutraceuticals: New Opportunities for Pharmacists Vol. 2 No. 3 212
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Vol. 2 No. 3 214
Basic Statistical Concepts for Evaluating the Pharmaceutical Compounding Literature: Part 4. Student's t-test and One-way Analysis of Variance Vol. 2 No. 3 216
Profile of a Practice: Office Practice Facilitates Compounding and Patient Counseling Vol. 2 No. 3 219
Acetylcysteine 15% Ophthalmic Solution Vol. 2 No. 3 222
Amphotericin B 2-mg/mL Ophthalmic Solution Vol. 2 No. 3 223
Ascorbic Acid 10% Ophthalmic Solution Vol. 2 No. 3 224
Calcium Gluconate 1% Ophthalmic Irrigation Solution Vol. 2 No. 3 225
Cyclosporine 2% Ophthalmic Solution Vol. 2 No. 3 226
Dexamethasone Sodium Phosphate 0.05% Ophthalmic Ointment Vol. 2 No. 3 227
Fluconazole 0.2% Ophthalmic Solution Vol. 2 No. 3 228
Fortified Gentamicin Ophthalmic Solution Vol. 2 No. 3 229
Glucose 40% Ophthalmic Ointment Vol. 2 No. 3 230
Idoxuridine 0.5% Ophthalmic Ointment Vol. 2 No. 3 231
Idoxuridine 0.1% Ophthalmic Solution Vol. 2 No. 3 232
Lissamine Green 0.5% Ophthalmic Solution Vol. 2 No. 3 233
Ophthalmic Lubricant Vol. 2 No. 3 234
Rose Bengal 1% Ophthalmic Solution Vol. 2 No. 3 235
Vancomycin 25-mg/mL Ophthalmic Solution Vol. 2 No. 3 236
Edetic Acid and Its Salts, Featured Excipient: Vol. 2 No. 3 237
Making Capsules Using a Solid Oral Dosage Form of a Different Strength Vol. 2 No. 3 240
Calculations Vol. 2 No. 3 241
General Aseptic Procedures Used at a Laminar Airflow Workbench Vol. 2 No. 3 242
Paclitaxel Compatibility with IV Express Filter Unit Vol. 2 No. 3 243
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL Vol. 2 No. 3 246
Sorption of Benzalkonium Chloride to Various Filters Used in Ophthalmics Vol. 2 No. 3 249
Compounding Dermatological Products Vol. 2 No. 4 260
Case Studies: Treating Dermatological Patients with Compounded Products Vol. 2 No. 4 266
Malathion 0.5% Lotion Vol. 2 No. 4 268
Malathion Topical Lotion: Therapy for Resistant Head Lice Vol. 2 No. 4 268
Treatment of Skin Aging with Topical Estrogens Vol. 2 No. 4 270
Dermatological Compounds from the Caribbean Vol. 2 No. 4 276
Antipruritic Cream (Same as Rash Cream) Vol. 2 No. 4 276
Anesthetic Lotion ( "Betacaine" ) Vol. 2 No. 4 277
Gentamicin- Betamethasone Otic ( " Gentasone" ) Vol. 2 No. 4 277
Nail Fungus Solution Vol. 2 No. 4 277
Swim Ear Drops ( "In Your Ear" ) Vol. 2 No. 4 277
Antipruritus Suspension (Stop Itch) Vol. 2 No. 4 277
Sunburn Lotion ("Soothe") Vol. 2 No. 4 278
Acyclovir with Lidocaine and Sunscreen Stick ( Herpes Ointment ) Vol. 2 No. 4 278
Lip Sunscreen and Protectant Vol. 2 No. 4 278
The Rewards of Treating Decubitus Ulcers Vol. 2 No. 4 282
Decubitus Ulcer Cream Vol. 2 No. 4 282
Tea Tree Oil Vol. 2 No. 4 284
Third Party Contracts and the Compounding Pharmacy Vol. 2 No. 4 286
Mailing and Shipping Medication: Challenges and Solutions Vol. 2 No. 4 288
Benzocaine 2% Anesthetic Gel Vol. 2 No. 4 296
Bleaching Cream Vol. 2 No. 4 297
Cocaine-Phenol-Tannic Acid Ointment Vol. 2 No. 4 298
Fluconazole in Dimethyl Sulfoxide Vol. 2 No. 4 299
Fluorouracil 5% Topical Stick Vol. 2 No. 4 300
Medicated Summer Gel Vol. 2 No. 4 301
Nicotinamide 4% Topical Gel Vol. 2 No. 4 302
1-2-3 Preparations Paste/Cream/Modified Cream Vol. 2 No. 4 303
Peeling Solutions Vol. 2 No. 4 304
Psoriasis Ointment Vol. 2 No. 4 305
Polyethylene Glycols, Featured Excipient: Vol. 2 No. 4 306
Standard Operating Procedure for Physical Quality Assessment of Ointments/Creams/Gels Vol. 2 No. 4 308
Calculations Vol. 2 No. 4 310
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist Vol. 2 No. 4 311
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form Vol. 2 No. 4 314
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Vol. 2 No. 4 318
Stability of Lorazepam in 5% Dextrose Injection Vol. 2 No. 4 322
PostScription: Outdated Literature Resources and the Pharmacist Vol. 2 No. 4 328
Compounded Nutritional Solutions - A Market Overview Vol. 2 No. 5 335
Parenteral Nutrition Equipment and Devices Vol. 2 No. 5 338
Catheter Occlusion: Causes and Solutions Vol. 2 No. 5 342
TPN Bulk Compounding from Bulk Drug Substances Vol. 2 No. 5 347
The Feasibility and Benefits of TPN in Horses: A Review of the Findings Vol. 2 No. 5 351
Model Parenteral Nutrition Formulation (Veterinary) Vol. 2 No. 5 352
Required Documentation for Home Infusion Pharmacies - Compounding Records Vol. 2 No. 5 354
Antique and Collectible Mortars and Pestles Vol. 2 No. 5 360
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids Vol. 2 No. 5 366
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids Vol. 2 No. 5 367
Pediatric Central Parenteral Nutrition Solution Vol. 2 No. 5 368
Pediatric Central Parenteral Nutrition Solution with Heparin Vol. 2 No. 5 369
Pediatric Peripheral Parenteral Nutrition Solution Vol. 2 No. 5 370
Three-in-One Adult Total Parenteral Nutrition Vol. 2 No. 5 371
Dextrose Injection and Dextrose, Featured Excipient: Vol. 2 No. 5 372
Balances and Weighing Accuracy Vol. 2 No. 5 376
Calculations Vol. 2 No. 5 378
Testing for Bacterial Endotoxins Vol. 2 No. 5 379
Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products Vol. 2 No. 5 380
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Vol. 2 No. 5 382
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions Vol. 2 No. 5 385
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits Vol. 2 No. 5 390
Stability of Albuterol in Continuous Nebulization Vol. 2 No. 5 394
Environmental Sensitivities: Summary of a Literature Search Vol. 2 No. 6 407
Environmental Sensitivities: Interview with Liliane J. Bartha, MD and Randy Mentzer, RPh Vol. 2 No. 6 409
Latex Allergy: A Brief Summary Vol. 2 No. 6 411
Alternatives for the Lactose-Intolerant Patient Vol. 2 No. 6 412
Warfarin 5-mg Sodium Capsules Vol. 2 No. 6 413
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Vol. 2 No. 6 414
Case Reports: Environmental Compounding Vol. 2 No. 6 417
DMPS 250-mg/5-mL Concentration Vol. 2 No. 6 417
Sulfamethoxazole/Trimethoprim Capsule (Preservative Free) 400-mg/80-mg Vol. 2 No. 6 418
Atropine Sulfate, Preservative-Free Solution 13 mcg/drop Vol. 2 No. 6 418
Book Review: Chemical Sensitivity: The Truth About Environmental Illness Vol. 2 No. 6 419
Veterinary Considerations: COPD in Horses Vol. 2 No. 6 420
Treating Patients Allergic to Poison Ivy Vol. 2 No. 6 421
Poison Ivy Extract Injection (10-mcg/mL) Vol. 2 No. 6 421
Introduction to Nuclear Pharmacy Vol. 2 No. 6 424
Physical Requirements for a Nuclear Pharmacy Vol. 2 No. 6 426
Nuclear Pharmacists Training and Certification Vol. 2 No. 6 427
Typical Day in a Nuclear Pharmacy Vol. 2 No. 6 428
Prescription Preparation in a Nuclear Pharmacy: Three Case Studies Vol. 2 No. 6 429
A Postsclerotherapy Discoloration Treatment Vol. 2 No. 6 432
Topical Ketoprofen for Fibromyalgia Vol. 2 No. 6 433
Amphotericin B 40-mg Vaginal Suppositories Vol. 2 No. 6 436
Beeswax Lip Balm with Sunscreen Vol. 2 No. 6 437
Buffered Aspirin 500-mg Capsules (Lactose Free) Vol. 2 No. 6 438
Dimercaptosuccinic Acid 100-mg capsules Vol. 2 No. 6 439
Dimercaptosuccinic Acid 100-mg/5-mL Suspension Vol. 2 No. 6 440
Oil and Alcohol Topical Vehicle (Preservative Free) Vol. 2 No. 6 441
Progesterone 200-mg/mL in Grapeseed-Oil Suspension Vol. 2 No. 6 442
Sertraline 7.5-mg Capsules Vol. 2 No. 6 443
Tannic Acid Cleaning Liquid Vol. 2 No. 6 444
Triple Estrogen 2.5-mg Capsules (Lactose Free) Vol. 2 No. 6 445
Triclosan Dental Floss: Winner-IJPC Formulations Contest, Mark Brandon Henegar Vol. 2 No. 6 446
Gelatin, Featured Excipient: Vol. 2 No. 6 450
Calculations Vol. 2 No. 6 453
Environmental Compounding Vol. 2 No. 6 454
Comparison of Job Satisfaction for Compounders and Noncompounders Vol. 2 No. 6 455
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes Vol. 2 No. 6 463
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion Vol. 2 No. 6 466
Home |  About  |  Contact  |  Advertising |  Privacy Policy                                                            ©2019 IJPC, Inc.